1. Huaxi Bio: leading medical beauty stock. Huaxi Bio's quarterly report for the fourth quarter of 2021 shows that the company realized total revenue of 1.936 billion, an increase of 86.77% year-on-year, with a net profit of 227 million, and a gross profit of 1.519 billion;
2. Aimer: a leading stock in medical beauty. The company realized total operating income of 425 million yuan in the fourth quarter of 2021, a year-on-year increase of 73.48%, and net profit of 244 million yuan, a year-on-year increase of 69.77%;
3, Goldfarb: a leading stock in medical beauty. The company's quarterly report for the third quarter of 2021 shows that total revenue of 78,927,500 yuan in the third quarter of 2021, an increase of -11.63% year-on-year; net profit of -10,072,000 yuan, an increase of -179% year-on-year;
4, Lanzi shares: a leading medical beauty industry, the holdings of the "Milan Park Feather", "crystal skin medical beauty" and "high life medical beauty" three domestic medical brand, strategic investment in South Korea's famous medical beauty service group DMG;
5, Huabang health: to build a skin specialty as the characteristics of the medical beauty brand The "Mane Skin" is currently the only chain of skin medical beauty specialties in China that integrates medicine, education and research.